Learn about biomarker testing to see if you could be eligible for TECELRA
View HCP Site View Patient Site
Full Prescribing Information Medication Guide
Find an ATC Connect with us

Stories of strength, hope, and inspiration

Watch the videos below to hear stories from people who truly understand what you’re going through. Whether you’re living with synovial sarcoma or supporting a loved one, these personal insights and experiences can offer guidance, support, and a reminder that you’re not alone.

Julie's advice for navigating synovial sarcoma

Julie Kramer, a 3x synovial sarcoma survivor, shares tips to help others take charge of their care and treatment.

Not all individuals in these videos have been treated with TECELRA.

Julie's advice for navigating synovial sarcoma

Julie's advice for navigating synovial sarcoma

Julie Kramer, a 3x synovial sarcoma survivor, shares tips to help others take charge of their care and treatment.

Julie's thoughts on the unmet needs in synovial sarcoma

Julie's thoughts on the unmet needs in synovial sarcoma

Hear what Julie Kramer has to say about the current unmet needs in the treatment of synovial sarcoma as well as good first steps to advocate for the best care possible.

Eldiara found purpose during a time of uncertainty

Eldiara found purpose during a time of uncertainty

Eldiara Doucette, diagnosed with synovial sarcoma at just 19, gets candid about her cancer journey in honor of Sarcoma Awareness Month.

Eldiara's thoughts on the importance of biomarker testing

Eldiara's thoughts on the importance of biomarker testing

Reflecting on her synovial sarcoma journey, Eldiara Doucette is speaking up about the important role biomarker testing plays in determining appropriate treatment options.

Not all individuals in these videos have been treated with TECELRA.

If you're ready to share your experience, we’d love to hear from you

Please complete the form below to share your story and help inspire others, raise awareness, and provide meaningful insights to people navigating this rare disease.

Share your story

*Required field except where noted.

keep exploring

See if TECELRA is an option for you
Not actual patients.

INDICATION and IMPORTANT SAFETY INFORMATION IMPORTANT SAFETY INFORMATION
and INDICATION

What is TECELRA?

TECELRA® is a medicine, called a genetically modified autologous T cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you.

IMPORTANT SAFETY INFORMATION

Important Warning: You will likely be in a hospital before and after getting TECELRA. TECELRA may cause side effects that can be severe or life-threatening. Call your healthcare provider or get emergency help right away if you get any of the following: fever (100.4°F/38°C or higher); chills/shivering; difficulty breathing; fast or irregular heartbeat; low blood pressure; fatigue; severe nausea, vomiting, or diarrhea; severe headache; or new skin rash. Tell all your healthcare providers that you were treated with TECELRA.

INDICATION and IMPORTANT SAFETY INFORMATION IMPORTANT SAFETY
INFORMATION and INDICATION

What is TECELRA?

TECELRA® is a medicine, called a genetically modified autologous T cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you.

IMPORTANT SAFETY INFORMATION

Important Warning: You will likely be in a hospital before and after getting TECELRA. TECELRA may cause side effects that can be severe or life-threatening. Call your healthcare provider or get emergency help right away if you get any of the following: fever (100.4°F/38°C or higher); chills/shivering; difficulty breathing; fast or irregular heartbeat; low blood pressure; fatigue; severe nausea, vomiting, or diarrhea; severe headache; or new skin rash. Tell all your healthcare providers that you were treated with TECELRA.

After getting TECELRA, you will be monitored daily at the healthcare facility for at least 7 days after the infusion. You should plan to stay close to a healthcare facility for at least 2 weeks. Do not drive, operate heavy machinery, or do other activities that could be dangerous for at least 2 weeks after you get TECELRA. Your healthcare provider will do blood tests to follow your progress. It is important that you have your blood tested. If you miss a scheduled appointment for your collection of blood, call your healthcare provider as soon as possible to reschedule.

Before you receive TECELRA, tell your healthcare provider about all the medicines and supplements you take and your medical conditions, including: seizure, stroke, confusion, or memory loss; heart, liver, or kidney problems; low blood pressure; lung or breathing problems; recent or active infection; past infections that can be reactivated following treatment with TECELRA; low blood counts; pregnancy, you think you may be pregnant, or plan to become pregnant; breastfeeding; or taking a blood thinner.

The most common side effects of TECELRA include nausea, fatigue, musculoskeletal pain, infection, fever (100.4°F/38°C or higher), constipation, vomiting, headache, diarrhea, cough, fast heart rate, swelling, shortness of breath, rash, increased aspartate aminotransferase, increased alanine aminotransferase, decreased lymphocyte count, decreased white blood cell count, decreased neutrophil count, decreased red blood cell count, and decreased platelet count.

You are encouraged to report side effects to the FDA at (800) FDA‑1088 or www.fda.gov/medwatch or to US WorldMeds at 1-855-246-9232.

What is TECELRA?

TECELRA® is a medicine, called a genetically modified autologous T cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you.

Please see Medication Guide, including Important Warning.

You are now leaving
this site

This link will take you to a third-party site that is not owned by US WorldMeds. Click “OK” if you would like to proceed or click “Cancel” to stay on this site.

OK
Cancel